Murch Oliver, Abdelrahman Maha, Collino Massimo, Gallicchio Margherita, Benetti Elisa, Mazzon Emanuela, Fantozzi Roberto, Cuzzocrea Salvatore, Thiemermann Christoph
Centre for Translational Medicine and Therapeutics, The William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary, University of London, Charterhouse Square, London, United Kingdom.
Crit Care Med. 2008 Feb;36(2):550-9. doi: 10.1097/01.CCM.0B013E3181620D2F.
Sphingosylphosphorylcholine (SPC) has been reported to activate a variety of G-protein coupled receptors, including S1P(1-5), G2A, GPR4, and OGR1 (GPR68). Interestingly, other structurally related lysophospholipid agonists of these receptors have been shown to exhibit immunomodulatory properties both in vitro and in vivo. These include prevention of tumor necrosis factor-alpha-induced monocyte adhesion to aortic endothelium in mice (sphingosine-1-phosphate via S1P(1-5) receptors) and reduction of organ injury and/or mortality in animal models of sepsis and endotoxemia (lysophosphatidylcholine via G2A). Here, we investigate the effects of SPC on the organ injury/dysfunction caused by systemic administration of lipopolysaccharide and the mechanisms underlying the observed effects of SPC.
Prospective, randomized study.
University-based research laboratory.
Sixty-one anesthetized male Wistar rats.
Rats received either SPC (10 mg/kg intravenously) or vehicle (phosphate-buffered saline 1 mL/kg intravenously) 15 mins before or 15 mins after induction of endotoxemia with lipopolysaccharide (6 mg/kg intravenously).
Treatment with SPC significantly reduced the organ/dysfunction injury caused by lipopolysaccharide. SPC pretreatment significantly reduced the circulating levels of interleukin-1beta and interleukin-6, the expression of CD11b (ligand for intercellular adhesion molecule-1) on circulating polymorphonuclear cells, the expression of proteins of intercellular adhesion molecule-1 (Western blot and immunohistochemistry), cyclooxygenase-2 and nuclear translocation of nuclear factor-kappaB (Western blot analysis), and inducible nitric oxide synthase (immunohistochemistry) as well as the lung injury caused by endotoxemia in the rat.
SPC reduced the organ injury/dysfunction caused by endotoxin in the rat. These beneficial effects of SPC are associated with potent anti-inflammatory effects.
据报道,鞘氨醇磷酸胆碱(SPC)可激活多种G蛋白偶联受体,包括S1P(1 - 5)、G2A、GPR4和OGR1(GPR68)。有趣的是,这些受体的其他结构相关溶血磷脂激动剂已被证明在体外和体内均具有免疫调节特性。其中包括预防肿瘤坏死因子 - α诱导的小鼠单核细胞黏附于主动脉内皮(通过S1P(1 - 5)受体的鞘氨醇 - 1 - 磷酸)以及在脓毒症和内毒素血症动物模型中降低器官损伤和/或死亡率(通过G2A的溶血磷脂酰胆碱)。在此,我们研究SPC对全身给予脂多糖所致器官损伤/功能障碍的影响以及SPC所观察到的效应的潜在机制。
前瞻性随机研究。
大学研究实验室。
61只麻醉的雄性Wistar大鼠。
在用脂多糖(静脉注射6 mg/kg)诱导内毒素血症前15分钟或后15分钟,大鼠接受SPC(静脉注射10 mg/kg)或溶剂(静脉注射1 mL/kg磷酸盐缓冲盐水)。
SPC治疗显著降低了脂多糖所致的器官/功能障碍损伤。SPC预处理显著降低了白细胞介素 - 1β和白细胞介素 - 6的循环水平、循环多形核细胞上CD11b(细胞间黏附分子 - 1的配体)的表达、细胞间黏附分子 - 1蛋白的表达(蛋白质印迹法和免疫组织化学法)、环氧合酶 - 2以及核因子 - κB的核转位(蛋白质印迹分析)、诱导型一氧化氮合酶(免疫组织化学法)以及大鼠内毒素血症所致的肺损伤。
SPC减轻了大鼠内毒素所致的器官损伤/功能障碍。SPC的这些有益作用与强大的抗炎作用相关。